Arcadia Biosciences (RKDA) Financials

$0.46

$-0.01 (-2.71%)

As on 08-Sep-2026 14:19EDT

Market cap

$1 Mln

Revenue (TTM)

$5 Mln

P/E Ratio

--

P/B Ratio

1.9

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	4.75	4.86	5.05	4.45	7.42	6.78
Cost of Revenue	3.11	3.10	2.96	2.17	6.10	8.71
Gross Profit	1.64	1.76	2.08	2.28	1.32	-1.93
Operating Expenses	5.70	11.76	5.73	8.38	15.32	33.60
Operating Profit (EBIT)	-4.06	-10.00	-3.65	-6.10	-14.01	-35.53
Other Income	--	--	--	--	--	--
Profit before Tax	-11.12	-2.33	-4.31	-5.32	-10.81	-16.13
Provision for Tax	0.01	0.01	0.01	0.01	0.01	0.00
Profit after Tax (Net Income)	-11.13	-2.34	-7.04	-13.98	-15.38	-14.66
Minority Interest	--	--	--	0.09	0.24	1.47
Consolidated Profit	--	--	--	--	--	-14.66

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	0.63	4.14	6.22	12.84	21.03	31.09
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	3.61	0.35	4.73	3.41	3.81	7.68
Current Liabilities	1.65	2.06	2.56	3.59	4.21	5.04
Total Liabilities	7.54	6.55	13.52	19.71	28.92	43.92

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	0.15	0.19	4.28	4.73	3.52	8.53
Current Assets	5.74	6.36	9.24	14.97	25.40	35.39
Total Assets	11.63	6.55	13.52	19.71	28.92	43.92
Total Debt*	--	--	0.16	1.01	2.02	3.29
Net Current Assets	--	4.30	6.68	11.38	21.19	30.35

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-4.74	-9.63	-15.29	-13.98	-25.87
Cash Flow from Investing Activities	--	0.75	7.34	-4.34	1.42	16.61
Cash from Financing Activities	--	0.01	0.01	5.51	4.52	21.90
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-8.14	-1.71	-5.16	-10.88	-24.96	-26.43
Cash EPS ($)	--	-1.69	-5.08	-10.63	-24.18	-24.55
Adjusted Book Value ($)	--	3.02	4.56	9.99	34.14	56.06
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-3.46	-7.06	-11.90	-22.69	-46.64
Free Cash Flow per Share ($)	--	-3.46	-7.07	-11.90	-22.80	-48.46

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-44.48	-69.59	-75.78	-53.54	-41.03
ROE (%)	-466.42	-45.14	-73.84	-82.55	-59.00	-49.85
ROA (%)	-104.72	-23.32	-42.37	-57.50	-42.22	-32.13
EBIT Margin (%)	-102.34	-47.98	-150.88	-135.11	-205.28	-424.12
Net Margin (%)	-234.53	-48.15	-139.50	-313.90	-207.28	-216.22
Cash Profit Margin (%)	-0.02	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	-12.24	-0.04	0.13	-0.40	0.09	-0.16
EBIT Growth (%)	8.70	69.38	-26.49	60.48	47.04	-371.16
Net Profit Growth (%)	-47.72	66.77	49.66	9.07	-4.88	-214.93
EPS Growth (%)	-47.39	0.67	0.53	0.56	0.06	-0.91
Book Value Growth (%)	-86.05	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-1.16	-1.15	-0.29	-0.01	-0.04
Price / Book Value	1.94	0.65	1.30	0.31	0.01	0.02
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.62	0.81	-0.53	1.15	1.25	0.90
Close Price ($)	0.68	1.98	5.92	3.13	10.84	41.60
High Price ($)	6.71	6.71	10.31	18.94	106.40	256.00
Low Price ($)	0.65	1.77	1.85	2.60	10.36	38.88
Market Cap ($ Cr)	1.14	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	--	0.02	0.08	0.10	0.11
Short term debt to equity ratio	--	--	0.02	0.07	0.05	0.03
Current Ratio	3.49	3.09	3.61	4.17	6.03	7.02
Quick Ratio	2.92	2.50	3.25	3.63	5.48	6.14
Interest Coverage	--	--	--	--	-52.69	-1,437.75

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	11.78	8.75	23.29	11.54	16.46	20.21
Asset Turnover	0.45	0.48	0.30	0.18	0.20	0.15
Receivable days	--	60.15	61.14	71.14	63.79	74.77
Inventory Days	--	124.74	176.40	359.45	202.17	172.91
Payable days	--	127.09	92.70	143.31	69.33	44.82
Cash Conversion Cycle	--	57.79	144.84	287.28	196.63	202.87

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.